Ethan Zohn Begins New Treatment

“Just know that although this war may seem long, you are winning
Just understand that the team in your fox hole is larger than your wildest dreams
Just realize that you are helping countless people in their own struggles just by being
Just believe that this will soon be a speed bump in your rear view mirror
Just keep the perspective and the faith
Just use this as a chance to continue to make a difference in this world”

This is an excerpt of an incredibly poem written by Stephen Brown for reality show Survivor winner Ethan Zohn, who is undergoing treatment for non-Hodgkin's leukemia.

If you’re following Zohn’s treatment at http://www.ezohn.com/, you know he is beginning his 30 days of isolation in “the bubble” for his stem cell transplant.

I have to admit I’m hooked on Zohn’s video diaries, which you can follow, too.
http://www.people.com/people/videos/0,,20331284,00.html

I would be remiss if I didn’t link to Cycle for Survival, one of the cancer charities he supports. Cycle for Survival is the indoor team cycling fundraiser that benefits lifesaving cancer research at Memorial Sloan-Kettering.
http://mskcc.convio.net/site/PageServer?pagename=cc_home

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap